English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Transcenta
Patient Daily
| May 4, 2023
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
Patient Daily
| Apr 21, 2023
Transcenta Presents Two Preclinical Studies at AACR 2023
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'
